Pharmaceutical Chemistry Research Laboratory, Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi-221005, India.
Mini Rev Med Chem. 2018;18(17):1442-1451. doi: 10.2174/1389557517666170220152651.
The incidence of Tuberculosis (TB) is baffling in developing countries due to the increase in multidrug-resistant and extensively drug-resistant TB. Therefore, drugs acting through different mechanisms are in dire need to counter the resistant strains. Various chemical scaffolds are being investigated against tuberculosis, among them the molecules containing phenothiazine nucleus are found to be more effective against both susceptible and resistant strains of M. tuberculosis. In addition, the efficacy of first-line drugs has been found to be enhanced on supplementary treatment with phenothiazines. The present review provides an overview of the phenothiazine based molecules which were investigated during the last ten years for their anti-tubercular activity.
由于耐多药和广泛耐药结核病的增加,发展中国家的结核病发病率令人费解。因此,急需作用机制不同的药物来对抗耐药菌株。人们正在研究各种针对结核病的化学支架,其中含有吩噻嗪核的分子被发现对结核分枝杆菌的敏感株和耐药株都更有效。此外,还发现联合使用吩噻嗪类药物可增强一线药物的疗效。本综述概述了过去十年中研究过的基于吩噻嗪的分子,它们具有抗结核活性。